Centrum bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1010 in its research report dated August 13, 2018.
HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 691 in its research report dated August 11, 2018.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 750 in its research report dated August 10, 2018.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 685 in its research report dated August 10, 2018.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated August 01, 2018.
Centrum Research is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated June 04, 2018.
Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated May 30, 2018.
Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1070 in its research report dated June 04,2018
Edelweiss recommended hold rating on Aurobindo Pharma with a target price of Rs 630 in its research report dated May 29, 2018.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated May 21, 2018.
Arihant Capital recommended accumulate rating on Aurobindo Pharma with a target price of Rs 728 in its research report dated April 10, 2018.
Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 909 in its research report dated February 09, 2018.
Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 904 in its research report dated November 13, 2017.
Centrum is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated November 10, 2017.
Geojit has recommended buy rating on Aurobindo Pharma with a target price of Rs 817 in its research report dated 1 September 2017.
Khambatta Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 800 in its research report dated August 11, 2017.
Axis Direct is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 16, 2017.
Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24, 2017.
Motilal Oswal recommended buy rating on Aurobindo Pharma with a target price of Rs 850 in its research report dated July 19, 2017.
Reliance Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 700 in its research report dated May 30, 2017.
HDFC Securities is bullish on Aurobindo has recommended buy rating on the stock with a target price of Rs 740 in its research report dated May 30, 2017.
Edelweiss recommended hold rating on Aurobindo Pharma with a target price of Rs 640 in its research report dated May 30, 2017.
ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 753 in its research report dated May 31, 2017.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 09, 2017.
Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 04, 2017.